Many users of a common asthma inhaler are poised to lose it in the new year, possibly due to changes to Medicaid rebate rules from the Biden administration.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.